The Increase in Thyroid Cancer Incidence is not only due to Papillary Microcarcinomas: a 40-year Study in 1 778 Patients

Abstract

Aims:

Thyroid cancer incidence has been increased over the last decades. The aims of the present study were: (a) to identify a changing trend in thyroid cancer in Northern Greece, (b) to examine patients’ and tumoral characteristics and (c) to investigate the increase of papillary microcarcinomas and that of invasive or larger cancers.

Patients and Methods:

We retrospectively analyzed the records of 1 778 patients who were diagnosed with thyroid cancer between January 1971 and December 2010. The study period was divided into 4 decades: 1971–1980, 1981–1990, 1991–2000, 2001–2010. Patients were separated into 2 groups: in Group A we have included papillary thyroid microcarcinomas (PTM) and in Group B all cancers with diameter >10 mm as well as invasive cancers ≤10 mm.

Results:

Patients diagnosed with thyroid cancer increased substantially per decade. The relative frequency of papillary thyroid cancer cases increased (from 60% up to 84.6% in the last decade) and follicular cancers decreased (from 40% down to 11.6%). During the study period, cancer size declined. Frequency of PTM (Group A) increased from 0% up to 19.3% in the last decade, but cancers of this group represent only a minority of total cancers.

Conclusions:

The increase of thyroid cancer in this cohort was mainly due to tumors larger than 1 cm and also to smaller in size but invasive thyroid tumors. This increase outnumbers the increase in papillary thyroid microcarcinomas.

Key words

thyroid - cancer - microcarcinoma - papillary - increase in thyroid cancer

• References

• 1 Colonna M, Grosclaude P, Remontet L et al. Incidence of thyroid cancer in adults recorded by French cancer registries (1978-1997). Eur J Cancer. 2002 38. 1762-1768
• 2 Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973–2002. JAMA 2006; 295: 2164-2167
• 3 Reynolds RM, Weir J, Stockton DL et al. Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin Endocrinol (Oxf) 2005; 62: 156-162
• 4 Mangano JJ. Geographic variation in U.S. thyroid cancer incidence and a cluster near nuclear reactors in New Jersey, New York, and Pennsylvania. Int J Health Serv 2009; 39: 643-661
• 5 How J, Tabah R. Explaining the increasing incidence of differentiated thyroid cancer. CMAJ 2007; 177: 1383-1384
• 6 Farahati J, Geling M, Mader U et al. Changing trends of incidence and prognosis of thyroid carcinoma in lower Franconia, Germany, from 1981–1995. Thyroid 2004; 14: 141-147
• 7 Davies L, Ouellette M, Hunter M et al. The increasing incidence of small thyroid cancers: where are the cases coming from?. Laryngoscope 2010; 120: 2446-2451
• 8 Hughes DT, Haymart MR, Miller BS et al. The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years. Thyroid 2011; 21: 231-236
• 9 Grodski S, Brown T, Sidhu S et al. Increasing incidence of thyroid cancer is due to increased pathologic detection. Surgery 2008; 144: 1038-1043
• 10 Gomez SI, Gallowitsch HJ, Kresnik E et al. Descriptive epidemiology of thyroid carcinoma in Carinthia, Austria: 1984-2001. Histopathologic features and tumor classification of 734 cases under elevated general iodination of table salt since 1990: population-based age-stratified analysis on thyroid carcinoma incidence. Thyroid 2004; 14: 277-286
• 11 Nam-Goong IS, Kim HY, Gong G et al. Ultrasonography-guided fine-needle aspiration of thyroid incidentaloma: correlation with pathological findings. Clin Endocrinol (Oxf) 2004; 60: 21-28
• 12 Pazaitou-Panayiotou K, Capezzone M, Pacini F. Clinical features and therapeutic implication of papillary thyroid microcarcinoma. Thyroid 2007; 17: 1085-1092
• 13 LiVolsi VA, Albores-Saavedra J, Asa SL et al. Papillary carcinoma. In: DeLellis RA, Lloyd RV, Heitz PU, Eng C. eds WHO classification of tumors: Pathology and Genetics – Tumors of Endocrine Organs. Lyon: IARC Press; 2004: 57-66
• 14 Koutras DA, Alevizaki M, Tsatsoulis A et al. Greece is iodine sufficient. Lancet 2003; 362: 405-406
• 15 Alevizaki M, Papageorgiou G, Rentziou G et al. Increasing prevalence of papillary thyroid carcinoma in recent years in Greece: the majority are incidental. Thyroid 2009; 19: 749-754
• 16 Rego-Iraeta A, Perez-Mendez LF, Mantinan B et al. Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma. Thyroid 2009; 19: 333-340
• 17 Scheiden R, Keipes M, Bock C et al. Thyroid cancer in Luxembourg: a national population-based data report (1983–1999). BMC Cancer 2006; 6: 102
• 18 Chow SM, Law SC, Au SK et al. Changes in clinical presentation, management and outcome in 1 348 patients with differentiated thyroid carcinoma: experience in a single institute in Hong Kong, 1960–2000. Clin Oncol (R Coll Radiol ) 2003; 15: 329-336
• 19 Hodgson NC, Button J, Solorzano CC. Thyroid cancer: is the incidence still increasing?. Ann Surg Oncol 2004; 11: 1093-1097
• 20 Garrel R, Tripodi C, Cartier C et al. Cervical lymphadenopathies signaling thyroid microcarcinoma. Case study and review of the literature. Eur Ann Otorhinolaryngol Head Neck Dis 2011; 128: 115-119
• 21 Liu S, Semenciw R, Ugnat AM et al. Increasing thyroid cancer incidence in Canada, 1970-1996: time trends and age-period-cohort effects. Br J Cancer 2001; 85: 1335-1339
• 22 Nixon IJ, Ganly I, Patel SG et al. Changing trends in well differentiated thyroid carcinoma over eight decades. Int J Surg 2012; 10: 618-623